<DOC>
	<DOCNO>NCT01468168</DOCNO>
	<brief_summary>To investigate safety efficacy DE-101 improve sign symptoms dry-eye disease .</brief_summary>
	<brief_title>A Study Assessing Safety Efficacy DE-101 Ophthalmic Suspension Dry Eye Patients</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<criteria>Individuals consider entry study either sex race : confirm diagnosis dry eye , willing use ocular treatment study study medication , correct Early Treatment Diabetic Retinopathy Study ( ETDRS ) visual acuity score +0.7 logarithm minimum angle resolution ( logMAR ) good eye , use contact lens study , Females childbearing potential must negative urine pregnancy test willing use acceptable method contraception eligible , continue participation , study , 18 year age old , able understand provide write informed consent Subjects follow eligible participate study : Fluorescein corneal stain conjunctival stain severe Conditions require use ophthalmic prescription counter medication study ( except study medication ) Any type current punctal occlusion include punctal plug , intracanalicular punctal plug cauterize puncta Any type ocular surgery within 90 day prior Visit 1 ( Day 1 ) Known history StevenJohnson 's syndrome , RileyDay syndrome , and/or ocular pemphigoid Ocular ( include lid ) disease/abnormality may interfere study Corneal transplant either eye , time prior enrollment study Laser refractive surgery le one year prior Visit 1 ( Day 1 ) Conditions require use systemic medication ongoing stable dosage least 30 day prior Visit 1 ( Day 1 ) Application isotretinoin within 30 day prior Visit 1 ( Day 1 ) Known allergy sensitivity study medication component Uncontrolled systemic condition condition would confound study evaluation endanger safety subject A woman pregnant , nursing , plan pregnancy Participation another investigational drug vaccine trial , participation trial within 30 day prior Visit 1 ( Day 1 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>